NRX Pharmaceuticals NRXP
NASDAQ NRXP
$2.40 -0.23 (-8.75%)
At close: Oct 22, 2026 · 4:00 PM EDT

NRX Pharmaceuticals (NRXP) Operating Leases (2025 - 2026)

Updated

NRX Pharmaceuticals (NRXP) recorded Operating Leases of $456,000 in Q2 2026, down 16.0% from the prior quarter.

Analysis

NRX Pharmaceuticals (NRXP) Operating Leases (2025 - 2026) Analysis & Trends

At the end of FY2025, NRX Pharmaceuticals reported Operating Leases of $315,000.

  • Quarterly Operating Leases has ranged from $158,000 in Q3 2025 to $543,000 in Q1 2026 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $543,000 (Q1 2026), $315,000 (Q4 2025) and $158,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 NRX Pharmaceuticals 103.58 Mn 55.17 Mn 426,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 456,000.00
Mar 31, 2026 543,000.00
Dec 31, 2025 315,000.00
Sep 30, 2025 158,000.00
API Access

NRX Pharmaceuticals Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=NRXP&period=max&api_key=YOUR_API_KEY